Clinical Experience With the Subcutaneous Implantable Cardioverter–Defibrillator in Adults With Congenital Heart Disease
Jeremy P. Moore(UCLA Health), Paul Khairy(Montreal Heart Institute), Robert H. Pass(Albert Einstein College of Medicine), Frank A. Fish(Vanderbilt University Medical Center), Stephen C. Cook(Children's Hospital of Pittsburgh), Blandine Mondésert(Montreal Heart Institute), Anitha S. John(Children's National), Michael S. Lloyd(Emory University), Jamil Aboulhosn(Adult Congenital Heart Association), Ali N. Zaidi(Albert Einstein College of Medicine), Kevin Shannon(City College of San Francisco)
Cited by 80
Related Papers
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
|Pathology & Oncology Research|2001|611
Recombinant Human Erythropoietin Stimulates Erythropoiesis and Reduces Erythrocyte Transfusions in Very Low Birth Weight Preterm Infants
|PEDIATRICS|1995|323
Multimodality Imaging Guidelines for Patients with Repaired Tetralogy of Fallot: A Report from the American Society of Echocardiography
|Journal of the American Society of Echocardiography|2014|311
Increased mortality among patients taking digoxin--analysis from the AFFIRM study
|European Heart Journal|2012|280
Clinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan Operation
|Journal of the American College of Cardiology|2014|224